Pharmacy
Lilly helping people prepare for disasters, making meds available
The 2019 Atlantic hurricane season begins June 1. With natural disasters and extreme weather on the rise, it’s critical to be prepared and ready to respond. That’s why Eli Lilly and Co.
Gilead Sciences names Mercier as CCO
Gilead Sciences announced that Johanna Mercier will join the company as chief commercial officer, and will become a member of the company’s senior leadership team. Mercier will assume responsibility for the company’s commercial operations effective July 1.
DIR relief urgency inspires over 4,700 letters to Congress
Already over the past week, NACDS RxIMPACT grassroots advocates have sent more than 4,700 letters to Congress. Their case is crucial: DIR relief is needed now for pharmacies’ viability and to reduce out-of-pocket drug costs for patients.
NACDS expands recommendations for opioid abuse prevention
ALEXANDRIA, Va. – The National Association of Chain Drug Stores (NACDS) has announced four more policy recommendations for opioid abuse prevention. The new proposals build on current policies backed by NACDS, which are achieving results at the federal and state levels.
Cancer mortality continues to decline
The latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decline in men, women, and children in the United States from 1999 to 2016. Overall cancer incidence rates, or rates of new cancers, decreased in men from 2008 to
Cardinal Health releases fifth edition of Oncology Insights
Oncologists said they see a growing role for artificial intelligence (AI) in improving the quality of care and patient outcomes according to new research from Cardinal Health Specialty Solutions.
Sen. Wyden visits NCPA board member’s community pharmacy
Sen. Ron Wyden (D, Ore.), ranking member of the Senate Finance Committee, this week visited Grants Pass Pharmacy in Grants Pass, Ore.
Pharmacy “DIR fee” loophole must close, NACDS RxIMPACT urges
The National Association of Chain Drug Stores (NACDS) RxIMPACT program has launched an Action Alert, urging Congress to provide “DIR fee” relief in time to save pharmacies and to reduce seniors’ out-of-pocket drug costs. Through NACDS RxIMPACT, pharmacy advocates are contacting U.S.
Lupin releases budesonide inhalation suspension
Lupin announced the launch of its budesonide inhalation suspension, 0.5 mg/2 mL single-dose ampules in the U.S. market, having received an approval from the United States Food and Drug Administration earlier. Lupin’s budesonide inhalation suspension, 0.
Hy-Vee advocates for fast DIR reform
Hy-Vee on Friday expressed dismay that a new Medicare rule did not provide relief from pharmacy direct and indirect remuneration (DIR) fees that inflate senior citizens’ prescription drug costs.
Upsher-Smith hosts pharmacy conference
Upsher-Smith recently hosted the National Alliance of State Pharmacy Associations (NASPA)/Pharmacists Mutual Leadership Conference at its Maple Grove headquarters on May 20-21, 2019.
FLAVORx now available at Walmart Neighborhood Markets
To help busy families, especially moms, who are dispensing antibiotics and other medications to sick little ones, Walmart is now offering FLAVORx with select liquid prescriptions for no additional cost at Neighborhood Market pharmacies.
Glenmark gets FDA’s nod for generic Vesicare
Glenmark Pharmaceuticals has gotten the okay from the Food and Drug Administration for solifenacin succinate tablets, in 5 mg and 10 mg dosages strengths. Solifenacin succinate tablets are the generic of Astellas Pharma’s Vesicare tablets, 5 mg and 10 mg.
Community pharmacists unite, learn, grow at McKesson ideaShare
McKesson ideaShare 2019 is the leading conference designed to help independent pharmacy owners and their staff grow their skills and build a stronger business.